Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howe Arlene RfiledCriticalHowe Arlene R
Publication of ECSP15021681ApublicationCriticalpatent/ECSP15021681A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona derivados tricíclicos fusionados de tiofeno, así como sus composiciones y métodos para su utilización, que modulan la actividad de la cinasa Janus (JAK) y que son útiles para el tratamiento de enfermedades relacionadas con la actividad de JAK incluyendo, por ejemplo, trastornos inflamatorios, trastornos autoinmunitarios, cáncer y otras enfermedades.The present invention provides fused tricyclic derivatives of thiophene, as well as their compositions and methods for their use, which modulate Janus kinase (JAK) activity and which are useful for the treatment of diseases related to JAK activity including, for example , inflammatory disorders, autoimmune disorders, cancer and other diseases.
ECIEPI201521681A2012-11-012015-06-01
FUSED TRICYCLIC DERIVATIVES OF THIOPHENE AS JAK INHIBITORS
ECSP15021681A
(en)